^Michaelson SD, Paulsen IM, Kozuska JL, Martin IL, Dunn SM (2013). "Importance of recognition loops B and D in the activation of human 5-HT3 receptors by 5-HT and meta-chlorophenylbiguanide". Neuropharmacology. 73: 398–403.
doi:
10.1016/j.neuropharm.2013.06.017.
PMID23810831.
S2CID2883317.
^Suryanarayanan A, Joshi PR, Bikádi Z, Mani M, Kulkarni TR, Gaines C, Schulte MK (2005). "The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide". Biochemistry. 44 (25): 9140–9.
doi:
10.1021/bi050661e.
PMID15966738.
^Schlicker E, Kathmann M, Exner HJ, Detzner M, Göthert M (1994). "the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex". Naunyn-Schmiedeberg's Archives of Pharmacology. 349 (1): 20–24.
doi:
10.1007/bf00178201.
PMID7908122.
S2CID8322690.
^Andrews N, File SE (1992). "Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?". Psychopharmacology. 108 (3): 333–7.
doi:
10.1007/BF02245120.
PMID1523283.
S2CID10407491.
^Dukat M, Young R, Darmani NN, Ahmed B, Glennon RA (June 2000). "The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay". Psychopharmacology. 150 (2): 200–7.
doi:
10.1007/s002130000410.
PMID10907673.
S2CID22484359.
^Michaelson SD, Paulsen IM, Kozuska JL, Martin IL, Dunn SM (2013). "Importance of recognition loops B and D in the activation of human 5-HT3 receptors by 5-HT and meta-chlorophenylbiguanide". Neuropharmacology. 73: 398–403.
doi:
10.1016/j.neuropharm.2013.06.017.
PMID23810831.
S2CID2883317.
^Suryanarayanan A, Joshi PR, Bikádi Z, Mani M, Kulkarni TR, Gaines C, Schulte MK (2005). "The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide". Biochemistry. 44 (25): 9140–9.
doi:
10.1021/bi050661e.
PMID15966738.
^Schlicker E, Kathmann M, Exner HJ, Detzner M, Göthert M (1994). "the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex". Naunyn-Schmiedeberg's Archives of Pharmacology. 349 (1): 20–24.
doi:
10.1007/bf00178201.
PMID7908122.
S2CID8322690.
^Andrews N, File SE (1992). "Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?". Psychopharmacology. 108 (3): 333–7.
doi:
10.1007/BF02245120.
PMID1523283.
S2CID10407491.
^Dukat M, Young R, Darmani NN, Ahmed B, Glennon RA (June 2000). "The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay". Psychopharmacology. 150 (2): 200–7.
doi:
10.1007/s002130000410.
PMID10907673.
S2CID22484359.